Wang et al. demonstrated that TIMP-2 inhibits cell invasion and migration by regulating MMP-9 at the mRNA or protein level and may be more effective than TIMP-2 or MMP-9 alone to predict the prognosis of patients with CRC [82]. This evidence concerns the gene TIMP2 and colorectal carcinoma.